Nurse-led Smoking Cessation With Further Follow-up in Lifestyle Centres - a Randomized Pilot Study
NCT ID: NCT04772144
Last Updated: 2022-10-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
58 participants
INTERVENTIONAL
2021-02-25
2022-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Nurse-led Smoking Cessation Program With Follow-up in Healthy Life Centres: a Randomized Clinical Trial
NCT05049174
Smoking Cessation in Cancer Treatment
NCT03328962
Nurse Smoking Cessation of Patients With Chronic Obstructive Pulmonary Disease (COPD) With Nicotine Replacement Therapy (NRT) and Behavioral Support
NCT00132236
Implementation of Smoking Cessation Support During Lung Cancer Workup
NCT05192031
Long-term Cancer Risk in the Randomised Oslo Diet and Antismoking Study
NCT03410641
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention group
behavioural and cessation aids
information, motivational interview, refferal to healty life-centers, free cessation aids
Control group
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
behavioural and cessation aids
information, motivational interview, refferal to healty life-centers, free cessation aids
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Hospitalized with a cardiovascular event (i.e. myocardial infarction, heart failure, unstable or stable angina, achyarrhythmias, bradyarrhythmias, carotid stenosis or claudication with need for peripheral revascularization)
* Sign informed consent and is expected to participate according to ICH / GCP
Exclusion Criteria
* Chronic renal failure stage 4 or known allergic reaction to varenicline
. Any condition (e.g. psychosis, alcohol abuse, dementia) or situation that may pose a significant risk to the participant, confuse the results or make participation unethical
* Lack of Norwegian and English knowledge
* Short life expectancy (\<12 months)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Oslo
OTHER
Norwegian Directorate of Health
OTHER_GOV
Oslo University Hospital
OTHER
Norwegian Institute of Public Health
OTHER_GOV
Vestre Viken Hospital Trust
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
John munkhaugen, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Vestre Viken Trust, Drammen hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Drammen Hospital
Drammen, Akershus, Norway
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
REK 202686
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.